[CLDX] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
24-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- -13.31%
YoY- -44.23%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 3,456 1,874 1,790 1,477 620 3,647 2,434 6.01%
PBT -22,923 -32,307 -32,684 -31,821 -22,062 -16,807 -12,294 10.93%
Tax -19,082 -5,090 836 -229 -137 -94 268 -
NP -3,841 -32,307 -32,684 -31,821 -22,062 -16,807 -12,732 -18.08%
Tax Rate - - - - - - - -
Total Cost 7,297 34,181 34,474 33,298 22,682 20,454 15,166 -11.46%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -111.14 -1,723.96 -1,825.92 -2,154.43 -3,558.39 -460.84 -523.09 -22.73%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -0.42 -4.49 -4.97 -5.33 -3.71 -4.03 -3.81 -30.73%
EPS Diluted -0.41 -4.49 -4.97 -5.33 -3.71 -4.03 -3.81 -31.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.